Page last updated: 2024-10-24

celecoxib and Carcinoma, Medullary

celecoxib has been researched along with Carcinoma, Medullary in 1 studies

Carcinoma, Medullary: A carcinoma composed mainly of epithelial elements with little or no stroma. Medullary carcinomas of the breast constitute 5%-7% of all mammary carcinomas; medullary carcinomas of the thyroid comprise 3%-10% of all thyroid malignancies. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1141; Segen, Dictionary of Modern Medicine, 1992)

Research Excerpts

ExcerptRelevanceReference
"Celecoxib has a good therapeutic potential for MTC to prevent metastasis growth, and its anti-tumoral effect is, at least in part, independent of PGE(2)."1.35Anti-tumoral effect of a celecoxib low dose on a model of human medullary thyroid cancer in nude mice. ( Cohen, R; Jullienne, A; Lausson, S; Lepoivre, M; Quidville, V; Segond, N; Tebbi, A, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Quidville, V1
Segond, N1
Tebbi, A1
Cohen, R1
Jullienne, A1
Lepoivre, M1
Lausson, S1

Other Studies

1 other study available for celecoxib and Carcinoma, Medullary

ArticleYear
Anti-tumoral effect of a celecoxib low dose on a model of human medullary thyroid cancer in nude mice.
    Thyroid : official journal of the American Thyroid Association, 2009, Volume: 19, Issue:6

    Topics: Animals; Blotting, Western; Carcinoma, Medullary; Caspase 3; Celecoxib; Cell Line, Tumor; Cell Proli

2009